Results 141 to 150 of about 7,361 (190)

Real-world safety assessment of tamsulosin based on adverse event analysis from the FAERS database. [PDF]

Sci Rep
Zhang Z, Lv L, Jiang F, Guan S, He D, Song H, Sun W, Tian F, Jiang S.   +8 more
europepmc   +1 more source

Evaluation of a low-intensity pulsed ultrasound for chronic prostatitis type IIIb/chronic pelvic pain syndrome: a randomized controlled trial. [PDF]

Front Reprod Health
Huang J, Liao Z, Zhao S, Lv B, Liang K.
europepmc   +1 more source

Construction of α_1A-Adrenoceptor-Based Stationary Phase Triggered by the Ultrahigh Affinity Protein Pair Colicin E7 Dnase /IM7 for Targeted Bioactive Compound Screening in Herba leonuri. [PDF]

J Sep Sci
Qiao X, Zhang H, Zhang Y, Liu Q, Guo J, Wang J.   +5 more
europepmc   +1 more source

Efficacy of external physical vibration lithecbole combined with tamsulosin in upper ureteric stones after ESWL: a prospective randomized clinical trial. [PDF]

Sci Rep
Xu HW, Liang X, Wang YH, Xu YX, Li HQ, Li YP.   +5 more
europepmc   +1 more source

Clarifications in JAMA Clinical Guidelines Synopsis.

JAMA
europepmc   +1 more source

Efficacy and Safety of Mirabegron in Males with Overactive Bladder and Lower Urinary Tract Symptoms: Analysis from an Integrated Database. [PDF]

Eur Urol Open Sci
Hadi FA, Schild A, Hansen MK, Anaokar S, Herschorn S.   +4 more
europepmc   +1 more source

Global stagnation and misaligned priorities in BPH drug development: a 25-year landscape analysis of clinical trial registries. [PDF]

NPJ Aging
Lv Z, Wang Y, Lv C, Lu Y, Cheng Q, Zhang H, Guo B, Gao F, Huang H, Li H, Yuan Q.   +10 more
europepmc   +1 more source

Tamsulosin, a selective \u3b11c adrenoceptor antagonist: a randomized controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH)

, 1995
Vaage, S., [et al.], Abrams, P., Wyndaele, J.J., Schulman, C.C.   +4 more
core  

Tamsulosin: an overview

World Journal of Urology, 2002
This article reviews the contemporary literature related to tamsulosin, which is now the most widely used alpha antagonist in treating benign prostatic hyperplasia. The primary emphasis of this article is on the clinical data that exist related to this agent.
Christopher, Chapple, Karl-Erik, Andersson   +1 more
openaire   +3 more sources

Tamsulosin combined with solifenacin versus tamsulosin monotherapy for male lower urinary tract symptoms: a meta-analysis

Current Medical Research and Opinion, 2015
To evaluate the efficacy and safety of tamsulosin and solifenacin combination therapy compared with tamsulosin monotherapy for male lower urinary tract symptoms (LUTS).
Runqiang Yuan, Shaopeng Qiu
exaly   +2 more sources